Xspray Pharma AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2015
Selling, General & Admin	203.88	169.57	109.6	58.38	47.1	Upgrade
Research & Development	79.36	40.26	22.22	38.57	6.55	Upgrade
Other Operating Expenses	-2.1	-29.06	-0.44	-	-0.01	Upgrade
Operating Expenses	281.14	180.77	131.38	96.95	53.65	Upgrade
Operating Income	-281.14	-180.77	-131.38	-96.95	-53.65	Upgrade
Interest Expense	-1.93	-0.68	-0.01	-0	-0.01	Upgrade
Interest & Investment Income	3.3	2.73	1.42	1.26	1.05	Upgrade
Currency Exchange Gain (Loss)	-5.9	-0.97	-1.69	-1	0.08	Upgrade
Other Non Operating Income (Expenses)	-0	-	-	-0	-	Upgrade
EBT Excluding Unusual Items	-285.67	-179.68	-131.67	-96.7	-52.52	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-	0.11	Upgrade
Pretax Income	-285.67	-179.68	-131.67	-96.7	-52.41	Upgrade
Income Tax Expense	-0.15	-0.02	-	-	-	Upgrade
Net Income	-285.52	-179.67	-131.67	-96.7	-52.41	Upgrade
Net Income to Common	-285.52	-179.67	-131.67	-96.7	-52.41	Upgrade
Shares Outstanding (Basic)	33	27	21	19	17	Upgrade
Shares Outstanding (Diluted)	33	27	21	19	17	Upgrade
Shares Change (YoY)	24.60%	26.21%	9.53%	11.77%	13.11%	Upgrade
EPS (Basic)	-8.62	-6.76	-6.25	-5.03	-3.05	Upgrade
EPS (Diluted)	-8.62	-6.76	-6.25	-5.03	-3.05	Upgrade
Free Cash Flow	-226.75	-205.97	-134.65	-52.92	-52.36	Upgrade
Free Cash Flow Per Share	-6.84	-7.74	-6.39	-2.75	-3.04	Upgrade
EBITDA	-272.59	-174.27	-123.04	-89.07	-46.95	Upgrade
D&A For EBITDA	8.55	6.49	8.34	7.89	6.69	Upgrade
EBIT	-281.14	-180.77	-131.38	-96.95	-53.65	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.